Research Grant
[Cite as https://purl.org/au-research/grants/nhmrc/510238]Researchers: Dr Aparajita Khatri (Principal investigator) , Prof Pamela Russell (Principal investigator)
Brief description Consistent with Cancer Australia and PCFA priorities, in preclinical studies we will evaluate triple therapy for advanced prostate cancer.The three treatments to be tested together are adenoviruses, gene therapy and docetaxel, each of which has therapeutic potential individually. The combination should increase therapeutic effiacy and decrease the doses required, thus reducing side effects and increasing quality of life. Results obtained should enable translation to a clinical trial.
Funding Amount $AUD 551,398.34
Funding Scheme NHMRC Project Grants
Notes New Investigator Grant
- nhmrc : 510238
- PURL : https://purl.org/au-research/grants/nhmrc/510238
